THE VACCINE
THE VACCINE, GROUP RDM MAGAZINE
THE VACCINE, GROUP RDM MAGAZINE
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
Ártico
Los qué todos leen
Reader Letter
The objective:
RDM Group in this publication, wants to make known
to all its readers the Beginning of the phase 3 clinical
trial of the investigational vaccine for COVID-19, all the
information was collected and provided by the institutions
involved, as well as the collaboration of researchers
of the area, of which the RDM group values and
recognizes the efforts of the authorities, each researcher,
and each research center in developing a vaccine
to eradicate COVID 19.
As well as the collaboration for the preparation and
monitoring of the RDM group at Mtra. Celia Dolores Ramírez
Rioja, to each of our Editors, designers, writers,
who contribute to the development of this document
month by month.
RDM Group
www.rdmrevista.com.mx
Los qué Todos Leen